Entourage Health Announces International Sale of Bulk Cannabis to Australia
TORONTO, July 04, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced today the successful sale, execution and fulfilment of its first international order of 100kg of bulk medical cannabis to Australia. The Company expands its medical portfolio in partnership with Lyphe Australia Pty Ltd. (“Lyphe”), a wholly-owned subsidiary of Lyphe Group Ltd., which specializes in medical cannabis access for patients. Lyphe will now offer four of the Company’s strains to their medical cannabis patients in Australia.
Related news for (ETRGF)
- Entourage Health Corp. Announces Closing of Plan of Arrangement
- Entourage Health Increases Senior Secured Credit Facility
- Entourage Health Corp. Announces Shareholder Approval of Going-Private Transaction
- Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
- Entourage Health Reports Strong Third Quarter 2024 Financial Results